Clinical Significance and Pathogenic Mechanisms of Long Non-Coding RNA TRPM2-AS in Cancers

Long non-coding RNAs (lncRNAs) are known to play vital roles in human cancers. LncRNA TRPM2-AS has been found to be upregulated in various types of cancers. The elevated levels of TRPM2-AS are associated with important clinicopathological parameters such as tumor size, tumor stage, and lymph node me...

Full description

Saved in:
Bibliographic Details
Main Authors: Shichen Huang MS, Bowen Li MS, Huanyu Chen MD, Cheng Rong, Zheng Yang MD, Xianqin Zhang PhD
Format: Article
Language:English
Published: SAGE Publishing 2025-01-01
Series:Technology in Cancer Research & Treatment
Online Access:https://doi.org/10.1177/15330338251315625
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832584506474758144
author Shichen Huang MS
Bowen Li MS
Huanyu Chen MD
Cheng Rong
Zheng Yang MD
Xianqin Zhang PhD
author_facet Shichen Huang MS
Bowen Li MS
Huanyu Chen MD
Cheng Rong
Zheng Yang MD
Xianqin Zhang PhD
author_sort Shichen Huang MS
collection DOAJ
description Long non-coding RNAs (lncRNAs) are known to play vital roles in human cancers. LncRNA TRPM2-AS has been found to be upregulated in various types of cancers. The elevated levels of TRPM2-AS are associated with important clinicopathological parameters such as tumor size, tumor stage, and lymph node metastasis, revealing that TRPM2-AS could be a potential target for cancer diagnosis, prognosis and treatment. Moreover, TRPM2-AS is involved in regulating the cell proliferation, migration, invasion, apoptosis, drug or radio resistance by serving as a competing endogenous RNA, directly bounding to proteins and regulating multiple signaling pathways. In this review, we comprehensively summarize the latest knowledge on the aberrant expression of TRPM2-AS, the relationship between TRPM2-AS and clinical features, and the detailed mechanisms of potential functions of TRPM2-AS in various cancer types. The current study highlights the potential of TRPM2-AS as a prognostic and therapeutic target in cancers.
format Article
id doaj-art-280678df8f4646648c6ea93d9cb7ba22
institution Kabale University
issn 1533-0338
language English
publishDate 2025-01-01
publisher SAGE Publishing
record_format Article
series Technology in Cancer Research & Treatment
spelling doaj-art-280678df8f4646648c6ea93d9cb7ba222025-01-27T13:03:45ZengSAGE PublishingTechnology in Cancer Research & Treatment1533-03382025-01-012410.1177/15330338251315625Clinical Significance and Pathogenic Mechanisms of Long Non-Coding RNA TRPM2-AS in CancersShichen Huang MS0Bowen Li MS1Huanyu Chen MD2Cheng Rong3Zheng Yang MD4Xianqin Zhang PhD5 School of Clinical Medicine, , 783 Xindu Avenue, Chengdu, 610500, Sichuan, China School of Clinical Medicine, , 783 Xindu Avenue, Chengdu, 610500, Sichuan, China School of Basic Medical Sciences, , 783 Xindu Avenue, Chengdu, 610500, Sichuan, China School of Basic Medical Sciences, , 783 Xindu Avenue, Chengdu, 610500, Sichuan, China School of Basic Medical Sciences, , 783 Xindu Avenue, Chengdu, 610500, Sichuan, China School of Basic Medical Sciences, , 783 Xindu Avenue, Chengdu, 610500, Sichuan, ChinaLong non-coding RNAs (lncRNAs) are known to play vital roles in human cancers. LncRNA TRPM2-AS has been found to be upregulated in various types of cancers. The elevated levels of TRPM2-AS are associated with important clinicopathological parameters such as tumor size, tumor stage, and lymph node metastasis, revealing that TRPM2-AS could be a potential target for cancer diagnosis, prognosis and treatment. Moreover, TRPM2-AS is involved in regulating the cell proliferation, migration, invasion, apoptosis, drug or radio resistance by serving as a competing endogenous RNA, directly bounding to proteins and regulating multiple signaling pathways. In this review, we comprehensively summarize the latest knowledge on the aberrant expression of TRPM2-AS, the relationship between TRPM2-AS and clinical features, and the detailed mechanisms of potential functions of TRPM2-AS in various cancer types. The current study highlights the potential of TRPM2-AS as a prognostic and therapeutic target in cancers.https://doi.org/10.1177/15330338251315625
spellingShingle Shichen Huang MS
Bowen Li MS
Huanyu Chen MD
Cheng Rong
Zheng Yang MD
Xianqin Zhang PhD
Clinical Significance and Pathogenic Mechanisms of Long Non-Coding RNA TRPM2-AS in Cancers
Technology in Cancer Research & Treatment
title Clinical Significance and Pathogenic Mechanisms of Long Non-Coding RNA TRPM2-AS in Cancers
title_full Clinical Significance and Pathogenic Mechanisms of Long Non-Coding RNA TRPM2-AS in Cancers
title_fullStr Clinical Significance and Pathogenic Mechanisms of Long Non-Coding RNA TRPM2-AS in Cancers
title_full_unstemmed Clinical Significance and Pathogenic Mechanisms of Long Non-Coding RNA TRPM2-AS in Cancers
title_short Clinical Significance and Pathogenic Mechanisms of Long Non-Coding RNA TRPM2-AS in Cancers
title_sort clinical significance and pathogenic mechanisms of long non coding rna trpm2 as in cancers
url https://doi.org/10.1177/15330338251315625
work_keys_str_mv AT shichenhuangms clinicalsignificanceandpathogenicmechanismsoflongnoncodingrnatrpm2asincancers
AT bowenlims clinicalsignificanceandpathogenicmechanismsoflongnoncodingrnatrpm2asincancers
AT huanyuchenmd clinicalsignificanceandpathogenicmechanismsoflongnoncodingrnatrpm2asincancers
AT chengrong clinicalsignificanceandpathogenicmechanismsoflongnoncodingrnatrpm2asincancers
AT zhengyangmd clinicalsignificanceandpathogenicmechanismsoflongnoncodingrnatrpm2asincancers
AT xianqinzhangphd clinicalsignificanceandpathogenicmechanismsoflongnoncodingrnatrpm2asincancers